Incyte (INCY) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Non-cash restructuring charges
Depreciation and amortization	40.86M
Stock-based compensation	68.6M
Loss on debt redemption
Accounts receivable	-6.71M
Prepaid expenses and other assets	-13.32M
Accounts payable	25.68M
Accrued and other current liabilities	15.02M
Deferred revenue
Net cash (used in) provided by operating activities
Capital expenditures	-104.41M
Sales and maturities of marketable securities	77.82M
Net cash (used in) provided by investing activities
Proceeds from issuance of common stock under stock plans
Redemption of convertible notes
Net cash provided by (used in) financing activities
Net decrease in cash and cash equivalents	58.66M
Cash and cash equivalents at beginning of period	521.44M
Cash and cash equivalents at end of period	580.1M

Entities mentioned with INCY

View All Entities